Georgia D. Montouris, MD
Clinical Associate Professor
Boston University School of Medicine
Dept of Neurology

MD, Free University of Brussels

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety to Brivaracetam in subjects (>16 to 80 years old) with partial onset seizures
06/01/2011 - 05/31/2012 (PI)
UCB Biosciences Inc.

A Phase 3, open-label, multicenter, follow-up study to evaluate the long-term safety and efficacy of Protocol #1379
06/01/2011 - 05/31/2012 (PI)
UCB Biosciences Inc.

Trileptal Pregnancy Registry
07/01/2006 - 06/30/2007 (PI)
Minnesota Epilepsy Group, P.A.

An Open-Label Extension Trial to Determine Safety and Efficacy of Long-Term Oral SPM 927 in Patients with Partial Seizures
10/06/2004 - 01/31/2007 (PI)
Schwarz Biosciences, Inc.

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600 mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization
04/01/2004 - 03/30/2006 (PI)
Schwarz Biosciences, Inc.

A Multi-Center, Open-Label, Long-Term, Follow-Up Study of the Safety and Efficacy of Levetiracetam in Children with Partial Onset Seizures
12/13/2004 - 12/12/2005 (PI)
UCB, Inc.

A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Patients with Primary Generalized Tonic-Clonic Seizures
12/10/2004 - 12/09/2005 (PI)
GlaxoSmithKline, Inc.

A Double-Blind, Randomized, Multicenter, Placebo-Controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age from
10/13/2004 - 10/12/2005 (PI)
UCB Pharma, Inc.

A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Subjects With Partial Seizures
09/27/2004 - 09/26/2005 (PI)
GlaxoSmithKline, Inc.

An Open-Label Extension Trial to Determine Tolerability and Efficacy of Long-Term Oral SPM 927 as Adjunctive Therapy in Patients with Partial Seizures
11/01/2003 - 10/31/2004 (PI)
Schwarz Biosciences, Inc.

Showing 10 of 13 results. Show All Results

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray…
02/03/2016 - 02/28/2017 (PI)
Acorda Therapeutics, INC

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Gidal BE, Wechsler RT, Sankar R, Montouris GD, White HS, Cloyd JC, Kane MC, Peng G, Tworek DM, Shen V, Isojarvi J. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study. Neurology. 2016 Oct 25; 87(17):1806-1812. PMID: 27683846.
  2. Piña-Garza JE, Chung S, Montouris GD, Radtke RA, Resnick T, Wechsler RT. Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature. Epilepsy Behav Case Rep. 2016; 5:38-43. PMID: 26977407; DOI: 10.1016/j.ebcr.2016.01.004;.
  3. Montouris G, Hohler AD. Cultural Barriers to Medication Adherence in Epilepsy. Continuum (Minneap Minn). 2016 Feb; 22(1 Epilepsy):266-9.View Related Profiles. PMID: 26844742; DOI: 10.1212/CON.0000000000000286;.
  4. Deck GM, Nadkarni N, Montouris GD, Lovett A. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010. Epilepsy Behav. 2015 Oct; 51:166-9. PMID: 26283306; DOI: 10.1016/j.yebeh.2015.07.001;.
  5. Montouris G, Yang H, Williams B, Zhou S, Laurenza A, Fain R. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel. Epilepsy Res. 2015 Aug; 114:131-40. PMID: 26088896; DOI: 10.1016/j.eplepsyres.2015.04.011;.
  6. Wong LC, Freeburg JD, Montouris GD, Hohler AD. Two patients with Hashimoto''s encephalopathy and uncontrolled diabetes successfully treated with levetiracetam. J Neurol Sci. 2015 Jan 15; 348(1-2):251-2.View Related Profiles. PMID: 25467138; DOI: 10.1016/j.jns.2014.11.007;.
  7. Montouris GD, Wheless JW, Glauser TA. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia. 2014 Sep; 55 Suppl 4:10-20. PMID: 25284033; DOI: 10.1111/epi.12732;.
  8. Spengler DC, Montouris GD, Hohler AD. Levetiracetam as a possible contributor to acute kidney injury. Clin Ther. 2014 Aug 1; 36(8):1303-6.View Related Profiles. PMID: 24986483; DOI: 10.1016/j.clinthera.2014.06.002;.
  9. Karakis I, Cole AJ, Montouris GD, San Luciano M, Meador KJ, Piperidou C. Caregiver burden in epilepsy: determinants and impact. Epilepsy Res Treat. 2014; 2014:808421. PMID: 24808956; DOI: 10.1155/2014/808421;.
  10. Karakis I, Montouris GD, Piperidou C, Luciano MS, Meador KJ, Cole AJ. Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures. Seizure. 2014 Jan; 23(1):47-54. PMID: 24140136; DOI: 10.1016/j.seizure.2013.09.011;.
Showing 10 of 58 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 57 publications over 19 distinct years, with a maximum of 7 publications in 2004


Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map

Montouris's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department